June 2024 Provider Newsletter

Contents

AdministrativeCommercialMedicare AdvantageJune 1, 2024

Availity Essentials single claim submission response reports

AdministrativeCommercialJune 1, 2024

Implant — Facility Editing update

AdministrativeCommercialJune 1, 2024

CAA: Review your online provider directory information

Digital SolutionsMedicare AdvantageApril 17, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs

Digital SolutionsCommercialMedicare AdvantageMay 23, 2024

Digital RFAI Availity training

Education & TrainingMedicare AdvantageJune 1, 2024

June is LGBTQIA+ Pride Month

Education & TrainingCommercialMedicare AdvantageMay 23, 2024

You are invited: Thriving, not just surviving: navigating challenging times as a clinician

Education & TrainingCommercialMedicare AdvantageJune 1, 2024

Introducing advanced eLearning features for MyDiversePatients.com

Medical Policy & Clinical GuidelinesMedicare AdvantageMay 7, 2024

Clinical Criteria updates

Medical Policy & Clinical GuidelinesCommercialMay 22, 2024

Medical Policies and Clinical Guidelines updates – June 2024

Medical Policy & Clinical GuidelinesCommercialApril 30, 2024

MCG Care Guidelines 28th edition

Medical Policy & Clinical GuidelinesMedicare AdvantageMay 1, 2024

MCG Care Guidelines 28th edition

Medical Policy & Clinical GuidelinesCommercialMedicare AdvantageMay 3, 2024

Carelon Medical Benefits Management, Inc. genetic testing code updates

Medical Policy & Clinical GuidelinesCommercialMay 28, 2024

Updates to Carelon Post-Acute Care Clinical Appropriateness Guidelines

Prior AuthorizationCommercialJune 1, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs

PharmacyMedicare AdvantageJune 1, 2024

Addressing medication adherence gaps

PharmacyMedicare AdvantageJune 1, 2024

Improving patient outcomes with statin therapy in diabetes

PharmacyCommercialJune 1, 2024

Pharmacy information available on our provider website

Quality ManagementCommercialMay 6, 2024

Enhance patient access to digital health resources

Quality ManagementCommercialApril 19, 2024

Improving patient health and digital literacies

Quality ManagementCommercialApril 24, 2024

Tips to Improve Adolescent Immunization (IMA) Rates

Quality ManagementCommercialMedicare AdvantageJune 1, 2024

New resources to improve your HEDIS® and CAHPS® quality rates

MOBCBS-CRCM-059379-24

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

AdministrativeCommercialMedicare AdvantageJune 1, 2024

Availity Essentials single claim submission response reports

Does your organization submit single claim submissions online to Availity Essentials? This feature is a no-cost option to submit your claims, but like all claim submissions, it’s important to review the response reports to ensure your claim has been accepted.

How do I view my response reports?

Your organization’s Availity administrator will need to assign the electronic data interchange (EDI) management role to users who submit online claim submissions. Even though the claims are submitted without using EDI software or a vendor, online claim submissions are still considered EDI transactions that will create response reports.

Once the role has been assigned, the user will have access to the EDI clearinghouse menu located under the Claims & Payments menu. The three tiles used are listed below:

  • Send and receive EDI files — The response files will be in the receive folder.
  • File restore — Availity will archive your response files after 60 days; use this option to restore your reports.
  • EDI reporting preferences — Select text > Human readable format. The other formats are only used for EDI software.

What kind of response reports do I need to view?

  • File acknowledgments — shows your claim has been received
  • Immediate batch response — acknowledges accepted claim and identifies if rejected due to HIPAA and/or payer-specific edits
  • Delayed payer reports — Certain policies will go through a second level of editing for the payer; This report will return if that is the case.

We are here to help

Availity Essentials offers on-demand recorded training and documentation to assist with reviewing your response reports:

  • Log in to Availity Essentials and select Help & Training > Get Trained.
  • Use the catalog filter and select EDI Clearinghouse; several courses will display for you to enroll in and view.
  • Use the EDI Companion Document to view the Setup EDI Reporting Preferences Chapter.
  • Contact Availity Client Services at 800-282-4548 Monday through Friday from 8 a.m. until 8 p.m.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-057175-24-CPN54585

AdministrativeCommercialJune 1, 2024

Implant — Facility Editing update

Effective for all claims received on and after September 1, 2024, Anthem is updating its outpatient facility editing system to deny the following HCPCS codes when billed with revenue code 0278:

A0001–A2012

C1052

A4212

C1600–C1604

A4215–A4217

C1761

A4220–A4221

C1765

A4290

C1787

A4305–A4306

C1748

A4314–A4316

C1818

A4338–A4351

Q4279

A4364

Q4287–Q4304

A4461

V2785

This facility editing update is supported by Anthem’s Implants — Facility commercial reimbursement policy. If you believe you have received a denial in error, please follow Anthem’s standard claim dispute process.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-057929-24-CPN57522

AdministrativeCommercialJune 1, 2024

CAA: Review your online provider directory information

Please review your online provider directory information on a regular basis to ensure that it’s correct. Access your online provider directory information by visiting anthem.com/provider, then at the top of the webpage, choose Find Care. Review your information and let us know if any of your directory information has changed.

Updating your information

Anthem uses the provider data management (PDM) capability available on Availity Essentials to update your provider or facility data. Using the Availity PDM capability meets the quarterly attestation requirement to validate provider demographic data set by the Consolidated Appropriations Act (CAA).

PDM features include:

  • Updating provider demographic information for all assigned payers in one location.
  • Attesting to and managing current provider demographic information.
  • Monitoring submitted demographic updates in real-time with a digital dashboard.
  • Reviewing the history of previously verified data.

Accessing the PDM application

Log on to Availity.com and select My Providers > Provider Data Management to begin using PDM. Administrators will automatically be granted access to PDM. Additional staff may be given access to PDM by an administrator. To find your administrator, go to My Account Dashboard > My Account > Organization(s) > Administrator Information.

PDM training

PDM training is available:

Not registered for Availity yet?

If you aren’t registered to use Availity Essentials, signing up is easy and 100% secure. There is no cost for providers to register or to use any of our digital applications. Start by going to Availity.com and selecting New to Availity? Get Started at the top of the home screen to access the registration page. If you have more than one tax ID number (TIN), please ensure you have registered all TINs associated with your account.

If you have questions regarding registration, reach out to Availity Client Services at 800-AVAILITY.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-058919-24

Digital SolutionsMedicare AdvantageApril 17, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs

This article was updated as of April 24, 2024

Effective October 1, 2024, Carelon Medical Benefits Management, Inc. will expand multiple programs to perform medical necessity reviews for additional procedures for Anthem members. Carelon Medical Benefits Management works to improve healthcare quality and manage costs for today’s most complex and prevalent tests and treatments, helping to promote care that is appropriate, safe, and affordable.

The expansion will require clinical appropriateness review for additional procedures related to Carelon Medical Benefits Management programs, including cardiology, radiation oncology, radiology, musculoskeletal, sleep, surgical, and additional outpatient services.

Carelon Medical Benefits Management will follow the clinical hierarchy established by Anthem for medical necessity determination. Anthem makes coverage determinations based on CMS guidance, including national coverage determinations (NCDs), local coverage determinations (LCDs), other coverage guidelines and instructions issued by CMS, and legislative changes in benefits. When existing guidance does not provide sufficient clinical detail, Carelon Medical Benefits Management will determine medical necessity using an objective, evidence-based process.

Carelon Medical Benefits Management will continue to use criteria documented in the Medical Policies and Clinical Guidelines of Anthem listed in the table below. These clinical guidelines can be found at Availity.com.

Detailed prior authorization (PA) requirements are available online by accessing the Precertification Lookup Tool under Payer Spaces at Availity.com. Contracted and noncontracted care providers should call Provider Services at the phone number on the back of the member’s ID card for PA requirements.

Prior authorization review requirements

Carelon Medical Benefits Management will begin accepting PA requests on September 24, 2024, for dates of service October 1, 2024, and after. For procedures scheduled to begin on or after October 1, 2024, care providers must contact Carelon Medical Benefits Management to obtain PA for the non‑emergency modalities below. Refer to the clinical guidelines on the microsite resource pages for complete code lists.

Program

Services

Medical Policies or Clinical Guidelines

Cardiovascular

  • OP cardiac hemodynamic monitoring with wireless sensor for heart failure management

  • Non-invasive heart failure and arrhythmia monitoring system

  • Carotid sinus baroreceptor stimulation devices
  • MED.00115
  • SURG.00124
  • MED.00134

Additional outpatient utilization management

  • Therapeutic apharesis

  • Hyperbaric oxygen therapy

  • Physiologic record of tremor

  • Home enteral and parenteral nutrition

  • Ambulance services

  • Virtual reality-assisted therapy systems

  • Home visual field monitor

  • Colonic irrigation

  • Automated evacuation of meibomian gland

  • Prothrombin time
    self-monitoring devices
  • CG-ANC-06
  • CG-DME-30
  • CG-MED-08
  • CG-MED-68
  • CG-MED-73
  • CG-MED-89
  • DME.00048
  • MED.00101
  • MED.00103
  • MED.00131
  • MED.00141

Musculoskeletal

  • Deep brain, cortical, and cerebellar stimulation
  • Implant of nerve stimulation devices
  • Extracorporeal shock wave therapy
  • SURG.00158
  • SURG.00026
  • SURG.00112
  • SURG.00045

Surgical

  • Surgical GI
  • Transendoscopic therapy
  • Surg. Tx of hyperhidrosis
  • Skin-related cosmetic and reconstructive services
  • Tonsilectomy/adenoidectomy
  • Cochlear and auditory brainstem implants
  • Implantable hearing aids
  • Drug-eluting devices to maintain sinus ostial patency
  • Temporomandibular disorders
  • Nasal valve repair
  • Minimally invasive Tx of posterior nasal nerve for rhinitis
  • Gastric electrical stimulation
  • Uterine fibroid ablation
  • Sacral nerve stimulatioon Tx of neurogenic bladder secondary to spinal cord injury
  • Vagus nerve stimulation
  • Ablation for solid tumors outside the liver
  • Intraocular telescope
  • Automated evacuation of meibomian gland
  • Intraocular anterior segment aqueous drainage devices
  • Implanted artificial iris devices
  • Implantable infusion pumps
  • Tx for urinary and fecal incontinence
  • Panniculectomy and abdominoplasty
  • Regenerative cell therapy and soft tissue augmentation
  • Products for wound healing and soft tissue grafting
  • Surgical and ablative Tx for chronic headaches
  • Intraoperative assessment of surgical margins during breast-conserving surgery
  • Mandibular/maxillary surgery
  • Penile prosthesis implantation
  • Diaphragmatic/phrenic nerve Stimulation and pacing systems
  • Radiofrequency ablation of renal sympathetic nerves
  • Synthetic cartilage implant for metatarsophalangeal joint disorders
  • Surgical Tx for OSA
  • Percutaneous vertebral disc/endplate procs.
  • ANC.00007
  • CG-MED-79
  • CG-SURG-08
  • CG-SURG-09
  • CG-SURG-116
  • CG-SURG-12
  • CG-SURG-30
  • CG-SURG-36
  • CG-SURG-61
  • CG-SURG-70
  • CG-SURG-79
  • CG-SURG-81
  • CG-SURG-82
  • CG-SURG-84
  • CG-SURG-95
  • CG-SURG-96
  • CG-SURG-99
  • MED.00103
  • MED.00132
  • SURG.00007
  • SURG.00010
  • SURG.00011
  • SURG.00077
  • SURG.00079
  • SURG.00096
  • SURG.00103
  • SURG.00129
  • SURG.00132
  • SURG.00135
  • SURG.00139
  • SURG.00147
  • SURG.00156
  • SURG.00157
  • SURG.00052

Sleep

  • Electronic positional devices for Tx of OSA
  • Surgical Tx for OSA
  • Implantable nerve stim.
  • Respiratory assist device
  • SURG.00129
  • DME.00042
  • SURG.00007
  • CMS Criteria
  • CG-SURG-95

To determine if PA is needed for a member on or after October 1, 2024, call Provider Services using the phone number on the back of the member’s ID card. Care providers using the interactive care reviewer (ICR) tool on Availity.com for PA requests on an outpatient procedure will receive a message referring the provider to Carelon Medical Benefits Management (Note: ICR cannot accept PA requests for services administered by Carelon Medical Benefits Management).

How to place a review request

Care providers may place a PA request online to Carelon Medical Benefits Management by way of providerportal.com. ProviderPortalSM is available 24/7, processing requests in real-time using clinical criteria.

For more information

For resources to help your practice get started with the cardiology, musculoskeletal, surgical, and programs, visit:

Our website helps you access information and tools such as order entry checklists, Clinical Guidelines, and FAQs.

Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare.

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-056610-24-CPN56138

Digital SolutionsCommercialMedicare AdvantageMay 23, 2024

Digital RFAI Availity training

In collaboration with Availity, we’ve developed self-paced training for your organization’s administrators about how to update the Medical Attachment registration.

Care providers enrolled in the Medical Attachments applications on Availity Essentials can now take advantage of faster claims processing through Digital Request for Additional Information (Digital RFAI). Receive digital notifications faster when additional documents are needed to process member claims.

Availity administrators can use this link to view the training on demand for Digital Request for Additional Information: Pre-check for Administrators.

We have also developed an enhanced training session for associates responsible for sending attachments. This training walks through the Attachments Dashboard and many of the unique features that make the dashboard most efficient.

Use thislink to register for the live trainings or to view the training on demand for Learn How to Submit Digital Requests for Additional Information (RFAI).

Register today!

  • June 11, 2024, from 2:30 to 3:30 p.m. ET
  • June 13, 2024, from 2:30 to 3:30 p.m. ET.

We are committed to finding solutions that help our care provider partners offer quality services to our members.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-057591-24-CPN57402

Education & TrainingMedicare AdvantageJune 1, 2024

June is LGBTQIA+ Pride Month

We strive to advance health equity so everyone has a fair opportunity to be at their healthiest. As we reduce barriers to whole health — physical, behavioral, and social — and personalize the healthcare journey, we can more effectively advance health equity. While focusing on understanding member needs, we actively develop educational tools for providers.

In recognition of June as National LGBTQIA+ Pride Month, we are introducing three eLearning tools on LGBTQIA+ health, available on the My Diverse Patients site. This site offers a comprehensive repository of resources for providers to help support the needs of diverse patients and address healthcare disparities. Multiple free continuing medical education (CME) courses are available, with CME credits offered through the American Academy of Family Physicians (AAFP).

For the month of June, our featured eLearning experience and resources are:

  • My Inclusive Practice — Improving Care for LGBTQIA+ Patients — a CME credit hour provider training. Course benefits:
    • Understand the fears and anxieties LGBTQIA+ patients often feel about seeking medical care.
    • Learn key health concerns of LGBTQIA+ patients.
    • Develop strategies for providing effective healthcare to LGBTQIA+ patients.
    • Review ideas for creating a welcoming office environment.
  • National LGBTQIA+ Health Education Center — Resources & Tools:
    • The National LGBTQIA+ Health Education Center provides educational programs, resources, and consultation to healthcare organizations with the goal of optimizing quality, cost‑effective healthcare for lesbian, gay, bisexual, and transgender people.
  • Pre-Exposure Prophylaxis (PrEP) Action KitResources & Tools:
    • The PrEP Action Kit includes clinical resources to help providers incorporate PrEP into their practices. Including helpful resources such as tips on taking a comprehensive sexual history, frequently asked questions about PrEP, and a pocket card about PrEP prescribing and monitoring, this action kit is an essential resource for all providers treating LGBTQIA+ patients or patients at risk of HIV infection.

These courses are designed for doctors (CME credit provided), nurses, health professionals, and medical office staff.

Providers can view these courses on their smartphone, tablet, or computer.

We're pleased to offer these resources as we work together to deliver high-quality, equitable healthcare.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-ALL-CRCM-059066-24-CPN58594

Education & TrainingCommercialMedicare AdvantageMay 23, 2024

You are invited: Thriving, not just surviving: navigating challenging times as a clinician

Join us to hear from a diverse panel of experienced professionals from Motivo and Anthem. During this interactive webinar, we will explore the recent research on the impact mental health has on providers and share insights into support services like counseling, stress management, and self-care resources.

Register today for the Thriving Not Just Surviving: Navigating Challenging Times as a Clinician forum hosted by Anthem and Motivo for Anthem providers.

Wednesday, June 26, 2024 | 3:30 to 5 p.m. ET

Please register for this event using this link: Forum registration

Recognizing the emotional stress providers often experience, this forum aims to deepen the discussion on mental health and the importance of prioritizing clinician’s self-care.

Together, we will work to foster a culture of understanding and support not just for clients, but for providers. By doing so, we work collaboratively for the health and wellbeing of all Americans and the communities in which we live and serve.

Each forum will continue the exploration of ways we can reduce disparities in healthcare, demonstrate cultural humility, have difficult and productive conversations, learn about valuable resources, and improve the health and wellbeing of our communities.

Also, join us in November, National Family Caregivers Awareness Month, for a webinar dedicated to supporting caregivers.

We are committed to working together to achieve improved outcomes and foster genuine collaboration with our care provider partners.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MOBCBS-CRCM-057130-24-CPN57088

Education & TrainingCommercialMedicare AdvantageJune 1, 2024

Introducing advanced eLearning features for MyDiversePatients.com

We have enhanced functionality on the eLearning platform MyDiversePatients.com.

This new functionality identifies learners and supports our ongoing commitment to health equity and cultural competency.

When a care provider (doctor, nurse, health professional, office staff) starts an online continuing medical education (CME) course, they now have the option to register a National Provider Identifier (NPI):

  • Flexibility: Self-paced learning gives the learner the freedom to decide when and where to take the trainings.
  • Multi-device accessibility: The course site is fully responsive and designed to work with multiple devices, including smartphone, tablet, and desktop. This means you can learn from the comfort of your home, while on the go, in the office, or any location of your choosing.
  • Progress tracking: The NPI registration allows the platform to monitor and track learning progress and achievements, helping health professionals to meet their CME requirements efficiently.
  • Credit management: Upon completion of a CME course and review of the recommended materials, the user has the opportunity to fill in a certificate of completion with the information they wish to appear on the document itself.
  • Find Care provider search tool: If the eLearner chooses to register their NPI when they take a CME course, progress is tracked to completion. The NPI number allows for a cultural competency indicator to appear beside the provider’s name in directories (Find Care). This is designed to support referring practitioners and members by being able to identify providers who have received certificates in cultural competency.

Goals of My Diverse Patients:

  • Offer a comprehensive repository of resources for care providers to help support the needs of diverse patients and address disparities.
  • Provide cultural competency for relevant resources from external sources (such as, medical journals and medical/quality organizations.)

Benefits:

  • Availability of multiple free CME resources — CME courses are offered through the American Academy of Family Physicians.
  • Real life stories about diverse patients and the unique challenges they face.
  • Tips for working with diverse patients to promote improvement in health outcomes.

New courses with CME credits and nursing continuing education units will be added in 2024. We look forward to working together to deliver equitable healthcare.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MOBCBS-CRCM-055977-24-CPN54448

Medical Policy & Clinical GuidelinesMedicare AdvantageMay 7, 2024

Clinical Criteria updates

Effective June 10, 2024

Summary: On May 19, 2023, August 18, 2023, November 17, 2023, December 11, 2023, and February 23, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. If you have questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other providers in your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

June 10, 2024

*CC-0258

iDoseTR (travoprost Implant)

New

June 10, 2024

*CC-0259

Amtagvi (lifleucel)

New

June 10, 2024

*CC-0260

Nexobrid (anacaulase-bcdb)

New

June 10, 2024

*CC-0199

Empaveli (pegcetacoplan)

Revised

June 10, 2024

*CC-0041

Complement Inhibitors

Revised

June 10, 2024

CC-0128

Tecentriq (atezolizumab)

Revised

June 10, 2024

CC-0116

Bendamustine agents

Revised

June 10, 2024

CC-0161

Sarclisa (isatuximab-irfc)

Revised

June 10, 2024

CC-0158

Enhertu (fam-trastuzumab deruxtecan-nxki)

Revised

June 10, 2024

CC-0157

Padcev (enfortumab vedotin)

Revised

June 10, 2024

CC-0230

Adstiladrin (nadofaragene firadenovec-vncg)

Revised

June 10, 2024

*CC-0125

Opdivo (nivolumab)

Revised

June 10, 2024

*CC-0119

Yervoy (ipilimumab)

Revised

June 10, 2024

*CC-0099

Abraxane (paclitaxel, protein bound)

Revised

June 10, 2024

*CC-0093

Docetaxel (Taxotere)

Revised

June 10, 2024

*CC-0094

Pemetrexed (Alimta, Pemfexy, Pemrydi)

Revised

June 10, 2024

CC-0130

Imfinzi (durvalumab)

Revised

June 10, 2024

*CC-0088

Elzonris (tagraxofusp-erzs)

Revised

June 10, 2024

*CC-0118

Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy (Azedra, Lutathera, Pluvicto, Zevalin)

Revised

June 10, 2024

*CC-0112

Xofigo (Radium Ra 223 Dichloride)

Revised

June 10, 2024

*CC-0123

Cyramza (ramucirumab)

Revised

June 10, 2024

*CC-0131

Besponsa (inotuzumab ozogamicin)

Revised

June 10, 2024

CC-0121

Gazyva (obinutuzumab)

Revised

June 10, 2024

CC-0122

Arzerra (ofatumumab)

Revised

June 10, 2024

CC-0232

Lunsumio (mosunetuzumab-axgb)

Revised

June 10, 2024

CC-0109

Zaltrap (ziv-aflibercept)

Revised

June 10, 2024

CC-0135

Melanoma Vaccines

Revised

June 10, 2024

*CC-0096

Asparagine Specific Enzymes

Revised

June 10, 2024

CC-0120

Kyprolis (carfilzomib)

Revised

June 10, 2024

*CC-0117

Empliciti (elotuzumab)

Revised

June 10, 2024

*CC-0126

Blincyto (blinatumomab)

Revised

June 10, 2024

CC-0113

Sylvant (siltuximab)

Revised

June 10, 2024

CC-0132

Mylotarg (gemtuzumab ozogamicin)

Revised

June 10, 2024

CC-0097

Vidaza (azacitidine)

Revised

June 10, 2024

CC-0129

Bavencio (avelumab)

Revised

June 10, 2024

*CC-0090

Ixempra (ixabepilone)

Revised

June 10, 2024

CC-0110

Perjeta (pertuzumab)

Revised

June 10, 2024

*CC-0115

Kadcyla (ado-trastuzumab)

Revised

June 10, 2024

*CC-0108

Halaven (eribulin)

Revised

June 10, 2024

CC-0089

Mozobil (plerixafor)

Revised

June 10, 2024

CC-0124

Keytruda (pembrolizumab)

Revised

June 10, 2024

*CC-0002

Colony Stimulating Factor Agents

Revised

June 10, 2024

*CC-0212

Tezspire (tezepelumab-ekko)

Revised

June 10, 2024

*CC-0033

Xolair (omalizumab)

Revised

June 10, 2024

*CC-0043

Monoclonal Antibodies to Interleukin-5

Revised

June 10, 2024

*CC-0029

Dupixent (dupilumab)

Revised

June 10, 2024

*CC-0208

Adbry (tralokinumab)

Revised

June 10, 2024

*CC-0062

Tumor Necrosis Factor Antagonists

Revised

June 10, 2024

*CC-0067

Prostacyclin Infusion and Inhalation Therapy

Revised

June 10, 2024

*CC-0066

Monoclonal Antibodies to Interleukin-6

Revised

June 10, 2024

*CC-0064

Interleukin-1 Inhibitors

Revised

June 10, 2024

*CC-0057

Krystexxa (pegloticase)

Revised

June 10, 2024

*CC-0068

Growth Hormones

Revised

June 10, 2024

*CC-0047

Trogarzo

Revised

June 10, 2024

*CC-0078

Orencia (abatacept)

Revised

June 10, 2024

*CC-0107

Bevacizumab for Non-ophthalmologic Indications

Revised

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-058781-24-CPN57659

Medical Policy & Clinical GuidelinesCommercialMay 22, 2024

Medical Policies and Clinical Guidelines updates – June 2024

The following Anthem’s Medical Policies and Clinical Guidelines were reviewed for Indiana, Kentucky, Missouri, Ohio, and Wisconsin.

To view Medical Policies and Clinical Utilization Management Guidelines, go to anthem.com > select Providers > select your state > under Provider Resources > select Policies, Guidelines & Manuals.

To help determine if prior authorization is needed for Anthem members, go to anthem.com > select Providers > select your state > under Claims > select Prior Authorization. You can also call the prior authorization phone number on the back of the member’s ID card.

To view medical policies and utilization management guidelines applicable to members enrolled in the Federal Employee Program® (FEP), visit fepblue.org > Policies & Guidelines.

Below are the current Clinical Guidelines or Medical Policies we reviewed, and updates were approved.

* Denotes prior authorization required

Policy/guideline

Information

Effective date

SURG.00019 Trans myocardial Revascularization

33140 Trans myocardial laser revascularization, by thoracotomy; (separate procedure) – Moving to Pre-Cert

9/1/2024

SURG.00032 Patent Foramen Ovale and Left Atrial Appendage Closure Devices for Stroke Prevention

33340 Percutaneous transcatheter closure of the left atrial appendage with endocardial implant, including fluoroscopy, transseptal puncture, catheter placement(s), left atrial angiography, left atrial appendage angiography, when performed, and radiological supervision and interpretation – Moving to Pre-Cert

9/1/2024

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-058742-24

Medical Policy & Clinical GuidelinesCommercialApril 30, 2024

MCG Care Guidelines 28th edition

Effective September 1, 2024, Anthem will upgrade to the 28th edition of MCG Care Guidelines for the following modules. Below is high level summary of the updates and is not intended to be all inclusive:

  • Behavioral Health Care (BHG):
    • The goal length of stay (GLOS) has been changed in two guidelines in the 28th edition of Behavioral Health Care.
  • Inpatient & Surgical Care (ISC):
    • The goal length of stay (GLOS) has been changed in a total of 72 Optimal Recovery Guidelines in the 28th edition of Inpatient & Surgical Care. In medical Optimal Recovery Guidelines, the GLOS has been changed in 37 guidelines, and the GLOS has been changed in 35 surgical Optimal Recovery Guidelines in the 28th edition of Inpatient & Surgical Care.
  • General Recovery Care (GRG):
    • Benchmark length of stay (BLOS) has been refined in the 28th edition of General Recovery Care.
  • Recovery Facility Care (RFC):
    • A total of one guideline has been removed from the 28th edition of Recovery Facility Care.
  • Chronic Care (CCG):
    • A total of 10 guidelines have been moved in the 28th edition of Chronic Care.

If you have questions, please contact the provider service number on the back of the member's ID card.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-056557-24-SRS56156

Medical Policy & Clinical GuidelinesMedicare AdvantageMay 1, 2024

MCG Care Guidelines 28th edition

Effective September 1, 2024, Anthem will upgrade to the 28th edition of MCG Care Guidelines for the following modules. Below is high level summary of the updates and is not intended to be all inclusive.

  • Behavioral Health Care (BHG)
    • The goal length of stay (GLOS) has been changed in 2 guidelines in the 28th edition of Behavioral Health Care.
  • Inpatient & Surgical Care (ISC)
    • The goal length of stay (GLOS) has been changed in a total of 72 Optimal Recovery Guidelines in the 28th edition of Inpatient & Surgical Care. In medical Optimal Recovery Guidelines, the GLOS has been changed in 37 guidelines and the GLOS has been changed in 35 surgical Optimal Recovery Guidelines, in the 28th edition of Inpatient & Surgical Care.
  • General Recovery Care (GRG)
    • The benchmark length of stay (BLOS) has been refined in the 28th edition of General Recovery Care.
  • Chronic Care (CCG)
    • A total of 10 guidelines have been moved in the 28th edition of Chronic Care.

For questions, please contact the provider service number on the back of the member's ID card.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-056697-24-CPN55820

Medical Policy & Clinical GuidelinesCommercialMedicare AdvantageMay 3, 2024

Carelon Medical Benefits Management, Inc. genetic testing code updates

Effective for dates of service on and after September 1, 2024, the following codes will require prior authorization through Carelon Medical Benefits Management, Inc.:

CPT® code

Description

81457

Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis, microsatellite instability

81458

Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis, copy number variants and microsatellite instability

81459

Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants, microsatellite instability, tumor mutation burden, and rearrangements

81462

Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (for example, plasma), interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants and rearrangements

81463

Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (for example, plasma), interrogation for sequence variants; DNA analysis, copy number variants, and microsatellite instability

81464

Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (for example, plasma), interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants, microsatellite instability, tumor mutation burden, and rearrangements

0420U

Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysis of 6 single-nucleotide polymorphisms (SNPs) genes TERT and FGFR3, urine, algorithm reported as a risk score for urothelial carcinoma

0422U

Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate

0423U

Psychiatry (for example, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition

0424U

Oncology (prostate), exosome-based analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as no molecular evidence, low-, moderate- or elevated-risk of prostate cancer

0425U

Genome (for example, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis, each comparator genome (for example, parents, siblings)

0426U

Genome (for example, unexplained constitutional or heritable disorder or syndrome), ultra-rapid sequence analysis

0428U

Oncology (breast), targeted hybrid-capture genomic sequence analysis panel, circulating tumor DNA (ctDNA) analysis of 56 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutation burden

0434U

Drug metabolism (adverse drug reactions and drug response), genomic analysis panel, variant analysis of 25 genes with reported phenotypes

0438U

Drug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes, including deletion/duplication analysis of CYP2D6, including reported phenotypes and impacted gene-drug interactions

As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management in one of several ways:

  • Access Carelon Medical Benefits Management’s ProviderPortalSM directly at providerportal.com.
    • Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
  • Access Carelon Medical Benefits Management via the Availity website at Availity.com.

If you have questions related to guidelines, contact Carelon Medical Benefits Management via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here.

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-056853-24-CPN56791

Medical Policy & Clinical GuidelinesCommercialMay 28, 2024

Updates to Carelon Post-Acute Care Clinical Appropriateness Guidelines

Effective for dates of service on and after September 1, 2024, the following updates will apply to the Carelon Medical Benefits Management Clinical Appropriateness Guidelines. As part of the Carelon Medical Benefits Management, Inc. guideline annual review process, these updates focus on advancing efforts to drive clinically appropriate, safe, and affordable healthcare services.

Updates

All post-acute care (PAC) guidelines — skilled nursing facility (SNF), inpatient rehabilitation facility (IRF), and long-term acute care hospital (LTACH):

  • Re-structured original guidelines into three separate, level of care-specific guidelines
  • Updated background and definitions and refined several criteria to be more applicable to each guideline after re-structuring
  • Removed most criteria pertaining to transfer between other levels of PAC
  • Removed facility accessibility and health-related social needs (HRSN) criteria
  • Removed requirement for physician referral
  • Added sub-criteria to existing criteria in ongoing care regarding remaining therapeutic goals
  • Added verbiage and examples for clarification of original intent or for more level of care-specific applicability

LTACH only:

  • Refined criteria around need for hospice/palliative care consultation

How to submit or check a prior authorization request

For SNF, IRF, or LTACH admissions, Carelon Medical Benefits Management will begin receiving requests on May 29, 2024, for members whose anticipated discharge date is June 1, 2024, or after.

Providers are encouraged to request authorization using NexLync. Go to the Carelon Medical Benefits Management website to get started. You can upload clinical information and check the status of your requests through this online tool seven days a week, 24 hours a day.

To learn more about Carelon Medical Benefits Management and upcoming training webinars, visit https://providers.carelonmedicalbenefitsmanagement.com/postacute or email PACprovider_relations@carelon.com.

If you are unable to access/use any of the links or have other questions, call the Carelon Medical Benefits Management Provider Call Center at 833-431-0780 during normal operating hours from 7 a.m. to 7 p.m. CT, Monday through Friday.

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-058856-24

Prior AuthorizationCommercialJune 1, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs

Effective October 1, 2024, Carelon Medical Benefits Management, Inc. will expand multiple programs to perform medical necessity reviews for additional procedures for Anthem members. Carelon Medical Benefits Management works to improve healthcare quality and manage costs for today’s most complex and prevalent tests and treatments, helping to promote care that is appropriate, safe, and affordable.

The continued migration will expand clinical appropriateness review for procedures related to the following existing Carelon Medical Benefits Management programs: cardiovascular, musculoskeletal, radiation oncology, radiology, sleep, and surgical. In addition, some codes will migrate into a new Carelon Medical Benefits Management solution — Additional outpatient UM (utilization management) that will include some transportation (including ambulance) and fertility procedures as set forth below. Transportation may include emergency post-service reviews.

The Clinical UM Guidelines and Medical Policies adopted by Anthem for medical necessity review are listed in the table below. Carelon Medical Benefits Management will begin accepting prior authorization requests on September 23, 2024, for dates of service on or after October 1, 2024.

Members included in the new program

Updates to Carelon Medical Benefits Management programs apply to select local fully insured Anthem members and select members who are covered under self-insured (ASO) benefit plans with services medically managed by Carelon Medical Benefits Management. This notice does not apply to certain HMO, BlueCard®, Medicare Advantage, Medicaid, Medicare Supplemental, or Federal Employee Program® (FEP®). For more information, please contact the phone number on the back of the member ID card.

Pre-service review requirements

For procedures that are scheduled to begin on or after October 1, 2024, all care providers must contact Carelon Medical Benefits Management to obtain pre-service review for the services including, but not limited to, the following non-emergency modalities. Please refer to the Clinical Guidelines at anthem.com > Providers > Provider Resources > Policies, Guidelines & Manuals for complete code lists.

Note: All codes will be reviewed for medical necessity for the requested service and not for site of care.

Program

Services

Medical Policies or Clinical Guidelines

Additional Outpatient Utilization Management

  • Fertility
  • Therapeutic Apharesis
  • Hyperbaric Oxygen Therapy
  • Physiologic Record of Tremor
  • Home Parenteral Nutrition
  • Imaging Evaluation. of Skin Lesions
  • Ambulance Services (not applicable to Connecticut)
  • Virtual Reality-Assisted Therapy Systems
  • Quantitative Sensory Testing
  • Automated Nerve Conduction Testing
  • Bioimpedance Spectroscopy
  • Autonomic Testing
  • Continuous Monitoring of Intraocular Pressure
  • Seizure Monitoring
  • Electronic Home Visual Field Monitoring
  • Eye Movement Analysis for Diagnosis of Concussion
  • High-volume Colonic Irrigation
  • Electrical Stimulation as a Treatment for Pain and Other Conditions
  • Sensory Stimulation for Brain-Injured Individuals in Coma or Vegetative State
  • Automated Evacuation of Meibomian Gland
  • Selected Sleep Testing
  • CG-ANC-04
  • CG-ANC-06
  • CG-MED-66
  • CG-MED-68
  • CG-MED-73
  • CG-MED-88
  • CG-MED-89
  • CG-SURG-35
  • DME.00048
  • LAB.00045
  • MED.00004
  • MED.00082
  • MED.00092
  • MED.00101
  • MED.00103
  • MED.00105
  • MED.00112
  • MED.00118
  • MED.00130
  • MED.00131
  • MED.00137
  • MED.00141
  • DME.00011
  • MED.00011
  • MED.00002

Cardiovascular

  • Intracardiac Ischemia Monitoring
  • Outpatient Cardiac Hemodynamic Monitoring w/Wireless Sensor for Heart Failure Management
  • Non-invasive Heart Failure and Arrhythmia Monitoring System
  • Carotid Sinus Baroreceptor Stimulation Devices
  • Venous Angioplasty w/wo stent placement
  • VeinEembolization as a Treatment for Pelvic Congestion Syndrome and Varicocele
  • Treatment of Varicose Veins (Lower Extremity)
  • Artery Stent Placement w/wo Angioplasty
  • Select Embolization procedures
  • Evaluation and Intervention for Dialysis Circuit Dysfunction
  • MED.00111
  • MED.00115
  • MED.00134
  • SURG.00124
  • SURG.00062
  • CG-SURG-106
  • CG-SURG-28
  • CG-SURG-76
  • CG-SURG-83
  • CG-SURG-93
  • CG-SURG-119
  • RAD.00059

Musculoskeletal

  • Ultrasound Bone Growth Stimulation.
  • Manipulation Under Anesthesia
  • Anesthesia for Interventional Pain Procedures.
  • Facet Joint Allograft Implants for Facet Disease
  • Peripheral Nerve Blocks for Treatment of Neuropathic Pain
  • Occipital Nerve Block Therapy for the Treatment of Headache and Occipital Neuralgia
  • Electrothermal Shrinkage of Joint Capsules, Ligaments and Tendons
  • Extracorporeal Shock Wave Therapy
  • Implant of Nerve Stimulation Devices
  • Radiofrequency Neurolysis and Pulsed Radiofrequency Therapy for Trigeminal Neuralgia
  • CG-MED-78
  • SURG.00114
  • SURG.00158
  • CG-DME-45
  • SURG.00112
  • CG-MED-65
  • CG-SURG-08
  • CG-SURG-89
  • SURG.00043
  • SURG.00045
  • SURG.00140
  • SURG.00144

Radiology

  • Magnetic Source Imaging & Magnetoencephalography
  • Low-Frequency Ultrasound Therapy for Wound Mgmt
  • Dynamic Spinal Visualization (Including Digital Motion X-ray & Cineradiography/ Videofluoroscopy)
  • Cervical and Thoracic Discography
  • CG-MED-76
  • MED.00096
  • RAD.00034
  • RAD.00053

Radiation Oncology

  • Neutron Beam Radiotherapy
  • THER-RAD.00008

Sleep

  • Electronic Positional Devices for Tx of OSA
  • Neuromuscular Electrical Training for Tx of OSA
  • Surgical Tx for OSA
  • DME.00042
  • DME.00043
  • SURG.00129

Surgical

Surgical GI:

  • High Resolution Anoscopy Screening
  • Doppler-Guided Transanal Hemorrhoidal Dearterialization

Base Surgical:

  • Anesthesia for Dental Services.
  • Skin Related Cosmetic and Reconstructive Services
  • Balloon Dilation of Eustachian Tubes
  • Functional Endoscopic Sinus Surgery
  • Bronchial Thermoplasty
  • Balloon Sinus Ostial Dilation
  • Cochlear and Auditory Brainstem Implants
  • Implantable Hearing Aids
  • Surgical Treatment for Obstructive Sleep Apnea and Snoring
  • Drug-Eluting Devices to Maintain Sinus Ostial Patency
  • Minimally Invasive Treatment of Posterior Nasal Nerve for Rhinitis
  • MRI Guided High-intensity Focused Ultrasound Ablation for Non-Oncologic Indications
  • Uterine Fibroid Ablation
  • Sacral Nerve Stimulation as a reatment of Neurogenic Bladder secondary to Spinal Cord Injury
  • Vagus Nerve Stimulation
  • Ablation for Solid Tumors Outside the Liver
  • Irreversible Electroporation
  • Corneal Collagen Cross Linking
  • Intraocular Telescope
  • Automated Evacuation of Meibomian Gland
  • Presbyopia and Astigmatism-correcting Intraocular Lenses
  • Viscocanalostomy and Canaloplasty
  • Intraocular Anterior Segment Aqueous Drainage Devices
  • Implanted Artificial Iris Devices
  • Implanted Port Delivery Systems for Ocular Disease
  • Implantable Infusion Pumps
  • Treatments for Urinary and Fecal Incontinence, Urinary Retantion
  • Reduction Mammaplasty
  • Mastectomy for Gynecomastia
  • Panniculectomy and Abdominoplasty
  • Adipose-derived Regenerative Cell Therapy and Soft Tissue Augmentation
  • Products for Wound Healing and Soft Tissue Grafting
  • Surgical and Ablative Treatments for Chronic Headaches
  • Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery with Radiofrequency Spectroscopy or Optical Coherence Tomography
  • Mandibular/Maxillary Surgery
  • Blepharoplasty, Repair and Brow Lift
  • Internal Rib Fixation Systems
  • Prostate Saturation Biopsy
  • Focal Laser Ablation for the Treatment of Prostate Cancer
  • Penile Prosthesis Implantation
  • Diaphragmatic/Phrenic Nerve Stimulation and Pacing Systems
  • High Intensity Focused Ultrasound Ablation for Oncologic Indications
  • Renal Sympathetic Nerve Ablation
  • Hysterectomy
  • Laparoscopic Gynecologic Surgery
  • Myomectomy
  • Transurethral Destruction, Prostate Tissue
  • Temporomandibular Disorders (SURG-09)
  • Septoplasty (SURG-18)
  • Bariatric Surgery and Other Treatment for Clinically Severe Obesity (SURG-81)
  • Nasal Valve Repair (SURG.00079)
  • Bone-Anchored and Bone Conduction Hearing Aids (SURG-82)

  • ANC.00007
  • CG-MED-41
  • CG-MED-79
  • CG-MED-81
  • CG-SURG-03
  • CG-SURG-08
  • CG-SURG-09
  • CG-SURG-105
  • CG-SURG-12
  • CG-SURG-117
  • CG-SURG-118
  • CG-SURG-120
  • CG-SURG-18
  • CG-SURG-24
  • CG-SURG-61
  • CG-SURG-71
  • CG-SURG-73
  • CG-SURG-79
  • CG-SURG-81
  • CG-SURG-82
  • CG-SURG-83
  • CG-SURG-84
  • CG-SURG-88
  • CG-SURG-95
  • CG-SURG-96
  • CG-SURG-99
  • MED.00057
  • MED.00103
  • MED.00132
  • SURG.00010
  • SURG.00011
  • SURG.00118
  • SURG.00061
  • SURG.00077
  • SURG.00079
  • SURG.00084
  • SURG.00095
  • SURG.00096
  • SURG.00107
  • SURG.00116
  • SURG.00120
  • SURG.00126
  • SURG.00129
  • SURG.00132
  • SURG.00135
  • SURG.00139
  • SURG.00141
  • SURG.00156
  • SURG.00157
  • SURG.00159
  • SURG.00160
  • MCG: ISC: S-660/660-RRG: Hysterectomy, Vaginal
  • MCG: ISC: S-450/450-RRG/5450: Laparotomy for Gynecologic Surgery, Including Myomectomy, Oophorectomy, and Salpingectomy
  • MCG: ISC: S-660/660-RRG: Hysterectomy, Vaginal
  • MCG: ISC: S-665/665-RRG: Hysterectomy, Laparoscopic
  • MCG: ISC: S-775/775-RRG: Laparoscopic Gynecologic Surgery, Including Myomectomy, Oophorectomy, and Salpingectomy

To determine if prior authorization is needed for a member on or after October 1, 2024, contact the Provider Services phone number on the back of the member’s ID card for benefit information. Care providers using the Interactive Care Reviewer (ICR) tool on Availity.com to pre-certify an outpatient procedure will receive a message referring the provider to Carelon Medical Benefits Management. (Note: ICR cannot accept prior authorization requests for services administered by Carelon Medical Benefits Management.)

Care providers should continue to submit pre-service review requests to Carelon Medical Benefits Management using the convenient online service via the Carelon Medical Benefits Management ProviderPortalSM. ProviderPortal is available 24 hours a day, seven days a week, processing requests in real-time using Clinical Criteria. Go to providerportal.com to register.

For more information

For resources to help your practice get started with the cardiology, musculoskeletal, radiology, sleep, surgical procedures, and radiation oncology programs, visit:

Our website at anthem.com helps you access information and tools such as order entry checklists, Clinical Guidelines, and FAQs. You can also contact your local network relations representative if you have any questions.

Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare.

* For New York, notice subject to regulatory approval.

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Carelon Insights, Inc. provides payment integrity services on behalf of the health plan.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-059094-24

PharmacyMedicare AdvantageJune 1, 2024

Addressing medication adherence gaps

Medications are the primary intervention in treating and preventing disease. For most conditions, medications need to be taken 80% or more of the time to see an improvement in clinical outcomes.

Forty to fifty percent of patients are non-adherent to their medications for chronic conditions, leading to 100,000 preventable deaths and $100 to $300 billion in preventable medical costs per year.*

How can we prevent and close adherence gaps?

Be aware of contributing factors that influence non-adherence:

  • Cognitive impairment
  • Fear of side effects
  • Too many medications
  • History of non-adherence
  • Lack of perceived benefit
  • Confusion
  • Transportation
  • Cost

Implement a standardized process to identify patients with non-adherence:

  • Ask about adherence at every appointment.
  • Incorporate patient questionnaires or patient interviews using open-ended questions into existing workflows.
  • Analyze non-adherence reporting or claims to identify patients.
  • Leverage your electronic health record to identify patients at risk for non-adherence.

Be proactive: Tailor the solution to the patient’s needs or concerns:

  • Simplify the medication regimen by considering once daily dosing.
  • Always educate patients on benefits and risks of taking or not taking their medications.
  • Leverage real-time prescription benefit to select lower cost and formulary medications during the electronic prescribing process.
  • Consider home delivery (mail) and 90-day supply to prevent refill gaps, avoid long waits at the pharmacy, and minimize transportation barriers.

Consider medication non-adherence first as a reason when a patient’s condition is not under control.

*Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J. 2018; 22:18-033. doi: 10.7812/TPP/18-033. PMID: 30005722; PMCID: PMC6045499.
Gooptu A, Taitel M, Laiteerapong N, Press VG. Association between Medication Non-Adherence and Increases in Hypertension and Type 2 Diabetes Medications. Healthcare (Basel). July 31, 2021; 9(8): 976. doi: https://doi.org/10.3390/healthcare9080976.
Brown M, Sinsky CA. Medication Adherence. Improve Patient Outcomes and Reduce Costs. American Medical Association Steps Forward. June 5, 2015. https://edhub.ama-assn.org/steps-forward/module/2702595. Accessed May 16, 2023.
Eight reasons patients don’t take their medications. American Medication Association. Feb 22, 2023. Accessed May 17, 2023.
https://ama-assn.org/delivering-care/patient-support-advocacy/8-reasons-patients-dont-take-their-medications.
El Halabi J, Minteer W, Boehmer KR. Identifying and Managing Treatment Nonadherence. Medical Clinics of North America. 2022; 106(4): 615-626. doi: https://doi.org/10.1016/j.mcna.2022.02.003.
Kini V, Ho PM. Interventions to Improve Medication Adherence. JAMA. 2018; 320(23): 2461. doi: https://doi.org/10.1001/jama.2018.19271.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-058771-24-CPN58567

PharmacyMedicare AdvantageJune 1, 2024

Improving patient outcomes with statin therapy in diabetes

Cardiovascular disease is the leading cause of death among people with diabetes. 1 National guidelines continue to recommend statin therapy in all patients with diabetes between the ages of 40 and 75, regardless of low-density lipoprotein (LDL) level, to prevent development of cardiovascular disease:

  • Reducing LDL-C levels by ~39 mg/dL with statin therapy can reduce heart disease and stroke mortality by 13%, regardless of the baseline LDL cholesterol levels.1
  • Nearly 60% of statin-eligible patients were never offered statin therapy by their doctor.2 Moreover, 50% of adults in the United States who would benefit from statins are taking them.3
  • Up to 34% of patients never fill the initial statin prescription (primary non-adherence).4

Statin Use in Patients with Diabetes (SUPD) is a CMS-adopted quality Star measure:

  • The SUPD measure is defined as percent of Medicare Part D beneficiaries 40 to 75 years old who were dispensed at least two diabetes medication fills and received a statin medication fill during the measurement period.
  • When assessing patients for appropriateness of statin therapy, also evaluate for potential measure exclusions.

Exclusions for the SUPD measure include:

  • End stage renal disease.
  • Hospice.
  • Rhabdomyolysis or myopathy.
  • Pregnancy/lactation.
  • Cirrhosis.
  • Pre-diabetes.
  • Polycystic ovary syndrome.
  • Fertility medication.

    • Reassess patient every year to evaluate the appropriateness of acceptable exclusions.
    • Exclusions require a submitted code each calendar year.

Best practices in initiating and improving statin adherence:

  • Offer statin therapy to all patients ages 40 to 75 years old who have diabetes, regardless of LDL.
  • Guidelines recommend moderate or high intensity statin depending on additional risks.
  • Get patient buy-in: Ask patients what they know about statins. Address any fears or concerns and educate them on statin benefits:
    • Fear of and perceived side effects are the most common reasons for declining or discontinuing statin therapy.4
  • Once a statin has been prescribed, follow up with patients to assess adherence.
  • Be aware of best practices to evaluate patient reported muscle side effects and an implementation strategy for re-initiation.

View a video about statins here.

References:

  1. American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S179–S218
  2. Bradley CK, Wang TY, Li S, et al. PatientReported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. Journal of the American Heart Association. 2019;8(7). doi: https://doi.org/10.1161/jaha.118.011765
  3. Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016. MMWR Morb Mortal Wkly Rep 2018;67:983–991. DOI: http://dx.doi.org/10.15585/mmwr.mm6735a4
  4. 2 Tarn DM, Barrientos M, Pletcher MJ, et al. Perceptions of Patients with Primary Nonadherence to Statin Medications. The Journal of the American Board of Family Medicine. 2021;34(1):123-131. doi: https://doi.org/10.3122/jabfm.2021.01.200262
  5. CDC. Statins and Diabetes: What You Should Know. Centers for Disease Control and Prevention. Published January 30, 2023. cdc.gov/diabetes/library/features/Statins_Diabetes.html
  6. Kearney PM, Blackwell L, Collins R, et al.; Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117–125
  7. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11). doi: https://doi.org/10.1161/cir.0000000000000678
  8. Collins R, Reith C, Emberson J, et al. The Lancet. 2016;388(10059):2532-2561. Interpretation of the evidence for the efficacy and safety of statin therapy. doi: https://doi.org/10.1016/s0140-6736(16)31357-5
  9. Hla D, Jones R, Blumenthal RS, et al. Assessing severity of statin side effects: Fact vs fiction. American College of Cardiology. April 09, 2018. Accessed May 17, 2023. acc.org/latest-in-cardiology/articles/2018/04/09/13/25/assessing-severity-of-statin-side-effects
  10. Reston JT, Buelt A, Donahue MP, Neubauer B, Vagichev E, McShea K. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease. Annals of Internal Medicine. 2020;173(10):806-812. doi: https://doi.org/10.7326/m20-4680

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-056672-24-CPN55983

PharmacyCommercialJune 1, 2024

Pharmacy information available on our provider website

Visit the Drug Lists page on our website at anthem.com/ms/pharmacyinformation/home.html for more information about:

  • Copayment/coinsurance requirements and their applicable drug classes.
  • Drug lists and changes.
  • Prior authorization criteria.
  • Procedures for generic substitution.
  • Therapeutic interchange.
  • Step therapy or other management methods subject to prescribing decisions.
  • Any other requirements, restrictions, or limitations that apply to using certain drugs.

The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October.

To locate the exchange, select Formulary and Pharmacy Information and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed.

Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at fepblue.org > Pharmacy Benefits.

Please call provider services to request a copy of the pharmaceutical information available online if you do not have internet access.

Through our efforts, we are committed to reducing administrative burden because we value you, our care provider partner.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-058761-24-CPN58712

Quality ManagementCommercialMay 6, 2024

Enhance patient access to digital health resources

Use this guide to help your patients better understand and use online health resources.

The Anthem.com/Provider Portal and Provider News Quality Management page contains training opportunities, resources, updates, pharmacy and behavioral health information, forms, and policies, and Availity information for billing.

Refer to attachment to view full details

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-054707-24-CPN54223

ATTACHMENTS (available on web): Enhance patient access to digital health resources (pdf - 0.42mb)

Quality ManagementCommercialApril 19, 2024

Improving patient health and digital literacies

Taking the time to help your patients boost their health and digital literacies can enhance trust and can lead to improved health outcomes and patient experience.

Refer to attachment to view full details

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-054705-24-CPN54222

ATTACHMENTS (available on web): Improving patient health and digital literacies (pdf - 0.47mb)

Quality ManagementCommercialApril 24, 2024

Tips to Improve Adolescent Immunization (IMA) Rates

Vaccines are important in reducing the incidence of morbidity and mortality due to serious preventable diseases. Except for the annual flu and COVID vaccines, most childhood vaccines are administered before six years of age. Once children enter their pre-teen years, it is time for them to get a few more vaccines. The Center for Disease Control (CDC) and the American Academy of Pediatrics recommend pre-teens 11 and 12 years old get three vaccines to prevent diseases: 1) tetanus, diphtheria, and pertussis (Tdap); 2) meningococcal disease; and, 3) cancers caused by the human papillomavirus (HPV).

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
1 Nandi, Arindam and Anita Shet. “Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination.” Human Vaccines and Immunotherapeutics. 220; 16(8): 1900-1904. tinyurl.com/3wshrt62.
2 Reference: Ventola, C. Lee. “Immunization in the United States: Recommendations, Barriers, and Measures to Improve Compliance.” Pharmacy and Therapeutics. 2016 Jul; 41(7): 426-436. tinyurl.com/4m7s2tcc 1/30/2024.

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CDCM-051220-24-CPN50915

ATTACHMENTS (available on web): Tips to Improve Adolescent Immunization (IMA) Rates (pdf - 0.24mb)

Quality ManagementCommercialMedicare AdvantageJune 1, 2024

New resources to improve your HEDIS® and CAHPS® quality rates

The Provider Quality and Health Equity team at Anthem has been hard at work creating and identifying resources to help improve quality rates and the overall experiences of your patients. Be sure to check the Quality Management section of this Provider Newsletter site periodically for resources and new content, including provider toolkits and HEDIS-related materials to help optimize your quality rates. New content, resources, webinars, and training opportunities are also available on the Clinical Quality Webinars Hub. Mydiversepatients.com is a great resource for training and resources to help you learn about and serve your diverse population.

We are committed to finding solutions that help our care provider partners offer high quality services to our members.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-052888-24-CPN50908

Quality ManagementCommercialMedicare AdvantageApril 22, 2024

Statin Use in Persons with Cardiovascular Disease (SPC) measure exclusion criteria: HEDIS® 2024 measurement year

Measure details

Eligibility criteria:

Numerator

Males 21 to 75 years of age and females 40 to 75 years of age as of December 31, 2024, who were dispensed at least one high- or moderate-intensity statin medication during 2024.

Denominator

Males 21 to 75 years of age and females 40 to 75 years of age as of December 31, 2024, who have been diagnosed with clinical atherosclerotic cardiovascular disease (ASCVD) during 2024.

Did you know?

Certain adverse reactions to a statin medication may exclude the patient from the measure denominator if properly documented. See required exclusions below.

Required exclusions:

  • Diagnosis of myalgia, myositis, myopathy, or rhabdomyolysis during 2024:
    • Important note: The above exclusionary diagnoses must be documented each year. A diagnosis from a prior year will not carry over to the current year.  These exclusionary diagnoses can come from claims or medical record data.  Medical record documentation must contain two patient identifiers.
  • Diagnosis of pregnancy during 2024
  • Diagnosis of in-vitro fertilization in 2023 or 2024
  • Dispensed at least one prescription for clomiphene during 2023 or 2024
  • 66 years of age and older who are enrolled in an Institutional Special Needs Plan (I-SNP) or living long term in an institution during 2024
  • 66 years of age and older with advanced illness during 2023 and/or 2024 and frailty during 2024
  • 66 years of age and older with advanced illness during 2023 and/or 2024 and dispensed dementia medication during 2024:
    • Note: Exclusions for advanced illness, frailty, and dispensed dementia medications must come from claims.
    • The advanced illness exclusion can include telephone visits, e-visits, and virtual check-ins to meet the two visits with an advanced illness diagnosis criterion.
  • Diagnosis of end-stage renal disease (ESRD) or dialysis during 2023 or 2024
  • Diagnosis of cirrhosis during 2023 or 2024
  • Hospice and palliative care
    • Death

Closing the gap

Documentation needed:

  • Only dispensed medication on a pharmacy claim is used to identify and close this gap.
  • Patient must use their member ID card when filling a statin prescription at the pharmacy.
  • Exclusions for advanced illness, frailty, and dispensed dementia medications must come from claims.
  • Exclusions for myalgia, myositis, myopathy, or rhabdomyolysis can come from claims or medical record data. Medical record documentation must include two patient identifiers.

Moderate- to high-intensity statin medications

Description

Prescription

High-intensity statin therapy

Atorvastatin 40 to 80 mg

Amlodipine-atorvastatin 40 to 80 mg

Rosuvastatin 20 to 40 mg

Simvastatin 80 mg

Ezetimibe-simvastatin 80 mg

Moderate-intensity statin therapy

Atorvastatin 10 to 20 mg

Amlodipine-atorvastatin 10 to 20 mg

Rosuvastatin 5 to 10 mg

Simvastatin 20 to 40 mg

Ezetimibe-simvastatin 20 to 40 mg

Pravastatin 40 to 80 mg

Lovastatin 40 mg

Fluvastatin 40 to 80 mg

Pitavastatin 1 to 4 mg

Best practices

Prescribe low-cost generics to eliminate cost as a barrier:

  • Atorvastatin, lovastatin, pravastatin, simvastatin, and rosuvastatin are available for $0 for extended days’ supply prescriptions. These medications are free using the Medicare Advantage prescription drug plan benefit for Anthem even if the patient reaches the coverage gap.
  • Encourage patients to fill their statin medication at a preferred pharmacy using their benefit.
  • Discourage the use of discount cards.
  • Let Anthem know of any patients filling outside of the benefit. Anthem can reach out to the pharmacy and/or patient regarding the $0 benefit cost.
  • Short trial fills of a statin medication with $0 cost may help hesitant patients be more willing to try or re-try a statin medication.

Help patients manage potential side effects:

  • Educate patients about the long-term cardiovascular benefits and potential side effects of a statin medication.
  • If a patient experienced statin intolerance previously, a trial of a lower dose or different statin medication may help reduce risk or side effects.

Note: Patient history of statin-induced myalgia, myositis, myopathy, or rhabdomyolysis in a prior year must be documented each year for patient to be excluded from this measure. A diagnosis from a prior year will not carry over to the current year.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

In Missouri (excluding 30 counties in the Kansas City area): Anthem Blue Cross and Blue Shield is the trade name of RightCHOICE® Managed Care, Inc. (RIT), Healthy Alliance® Life Insurance Company (HALIC), and HMO Missouri, Inc. RIT and certain affiliates administer non-HMO benefits underwritten by HALIC and HMO benefits underwritten by HMO Missouri, Inc. RIT and certain affiliates only provide administrative services for self-funded plans and do not underwrite benefits. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-055731-24-CPN55314